Previous Close | 16.04 |
Open | 15.90 |
Bid | 15.82 x 100 |
Ask | 16.03 x 100 |
Day's Range | 15.29 - 15.96 |
52 Week Range | 11.83 - 28.80 |
Volume | |
Avg. Volume | 748,493 |
Market Cap | 780.269M |
Beta (5Y Monthly) | 1.32 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Key Insights Significantly high institutional ownership implies REGENXBIO's stock price is sensitive to their trading...
Regenxbio Inc (NASDAQ:RGNX), a biotechnology company focused on the development, commercialization, and licensing of recombinant adeno-associated virus (AAV) gene therapy, has reported an insider sale according to a recent SEC filing.
Regenxbio Inc (NASDAQ:RGNX), a biotechnology company focused on the development, commercialization, and licensing of recombinant viral vectors for use in gene therapy, has reported an insider sale according to a recent SEC filing.